SCYX FY 2013 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$38M

FY 2013 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$17M+0.1% YoY

Gross Profit

$552,0003.3% margin

Operating Income

-$7M-42.7% margin

Net Income

-$30M-180.7% margin

EPS (Diluted)

$-192.64

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$5M

Stock-Based Comp.

$180,000

Balance Sheet

Total Assets

$12M

Total Liabilities

$21M

Stockholders' Equity

-$9M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$17M	+0.1%
Gross Profit	$552,000	$2M	-77.7%
Operating Income	-$7M	-$8M	+7.5%
Net Income	-$30M	-$11M	-165.4%